Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS), associated with high mortality rate, affects up to 67% of hospitalized COVID-19 patients. Early evidence indicated that the pathogenesis of COVID-19 evoked ARDS is, at least partially, mediated by hyperinflammatory cytokine storm in which interleukin 6 (IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Segú-Vergés, Cristina, Artigas, Laura, Coma, Mireia, Peck, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931125/
https://www.ncbi.nlm.nih.gov/pubmed/36791125
http://dx.doi.org/10.1371/journal.pone.0280677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931125/
https://www.ncbi.nlm.nih.gov/pubmed/36791125
http://dx.doi.org/10.1371/journal.pone.0280677

Ejemplares similares